Ok Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018
March 27, 2019 at 04:34 pm EDT
Share
OK Biotech Co., Ltd. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was TWD 1,120.346 million compared to TWD 1,233.076 million a year ago. Operating income was TWD 137.108 million compared to TWD 130.579 million a year ago. Net income was TWD 161.362 million compared to TWD 126.809 million a year ago. Basic earnings per share was TWD 2.15 compared to TWD 1.93 a year ago. Diluted earnings per share was TWD 2.09 compared to TWD 1.86 a year ago.
OK Biotech Corporation is principally engaged in the manufacture and distribution of medical supplies and products. The Company primarily provides household medical glucose meters and disposable glucose testing strips. Its products are applied in the testing and monitoring of glucose value for diabetes patients, hospitals, clinic doctors and nurses, among others. The Company distributes its products principally in Taiwan, other Asian markets and the United States.
OK BIOTECH CO., LTD. 
